Literature DB >> 21185154

Effect of preoperative hemoglobin A1c levels on long-term outcomes for diabetic patients after off-pump coronary artery bypass grafting.

Ryo Tsuruta1, Katsumi Miyauchi, Taira Yamamoto, Shizuyuki Dohi, Keiichi Tambara, Tomotaka Dohi, Hirotaka Inaba, Kenji Kuwaki, Hiroyuki Daida, Atsushi Amano.   

Abstract

BACKGROUND: Diabetes mellitus is an independent risk factor for cardiovascular events after coronary artery bypass grafting (CABG), and hemoglobin A1c (HbA1c) is the most convenient marker for monitoring glycemic control among diabetic patients. However, few studies have reported the impact of baseline HbA1c levels on outcomes for diabetic patients after CABG. This study therefore aimed to investigate whether preoperative HbA1c levels in diabetic patients are predictive of long-term outcomes after off-pump CABG (OPCAB). METHODS AND
RESULTS: Of 893 patients undergoing primary isolated OPCAB at Juntendo University Hospital from July 2002 to December 2007, subjects comprised 306 diabetic patients <80 years old. We divided these patients into 3 groups according to the preoperative HbA1c levels. No significant differences in baseline characteristics, angiographic findings, or operative parameters were apparent among the 3 groups. No operative or in-hospital mortality occurred. All-cause mortality and cardiac mortality rates were 6.2% (19 cases) and 1.3% (4 cases), respectively. Kaplan-Meier's survival showed no significant differences in all-cause or cardiac mortality (log-rank test, p=0.26, p=0.17, respectively). Multivariate analysis by Cox's proportional hazards model also demonstrated that no covariates predicted mortality except for age.
CONCLUSIONS: Preoperative HbA1c levels might not predict long-term outcomes for diabetic patients undergoing OPCAB. Careful evaluation for diabetes should be needed in preoperative management of CABG.
Copyright © 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185154     DOI: 10.1016/j.jjcc.2010.11.003

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  11 in total

Review 1.  Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery?

Authors:  Charlene Tennyson; Rebecca Lee; Rizwan Attia
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-09-10

2.  Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting.

Authors:  Thomas Nyström; Martin J Holzmann; Björn Eliasson; Ann-Marie Svensson; Jeanette Kuhl; Ulrik Sartipy
Journal:  Heart Vessels       Date:  2016-07-11       Impact factor: 2.037

3.  Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease.

Authors:  Laura Flink; Heidi Mochari-Greenberger; Lori Mosca
Journal:  Am Heart J       Date:  2013-04-06       Impact factor: 4.749

Review 4.  Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis.

Authors:  Yao Liu; Yan-min Yang; Jun Zhu; Hui-qiong Tan; Yan Liang; Jian-dong Li
Journal:  Cardiovasc Diabetol       Date:  2011-11-10       Impact factor: 9.951

5.  Insulin infusion on postoperative complications of coronary artery bypass graft in patients with diabetes mellitus.

Authors:  Gholamreza Masoumi; Rasoul Frasatkhish; Hamid Bigdelian; Mohsen Ziyaefard; Ali Sadeghpour-Tabae; Mojtaba Mansouri; Alireza Jalali
Journal:  Res Cardiovasc Med       Date:  2014-04-01

6.  Hemoglobin A1c and preoperative glycemia as a decision tool to help minimise sternal wound complications: a retrospective study in OPCAB patients.

Authors:  Jef Van den Eynde; Abel Van Vlasselaer; Annoushka Laenen; Delphine Szecel; Bart Meuris; Tom Verbelen; Steven Jacobs; Peter Verbrugghe; Wouter Oosterlinck
Journal:  J Cardiothorac Surg       Date:  2021-07-20       Impact factor: 1.637

Review 7.  Does HbA1c Level Have Clinical Implications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting? A Systematic Review and Meta-Analysis.

Authors:  Jia Zheng; Jing Cheng; Tong Wang; Qian Zhang; Xinhua Xiao
Journal:  Int J Endocrinol       Date:  2017-09-17       Impact factor: 3.257

8.  Impact of elevated glycosylated hemoglobin on hospital outcome and 1 year survival of primary isolated coronary artery bypass grafting patients.

Authors:  Mona Ramadan; Ahmed Abdelgawad; Ahmed Elshemy; Emad Sarawy; Aly Emad; Mahmoud Mazen; Ahmed Abdel Aziz
Journal:  Egypt Heart J       Date:  2017-10-27

9.  Dose-response analysis between hemoglobin A1c and risk of atrial fibrillation in patients with and without known diabetes.

Authors:  Huilei Zhao; Menglu Liu; Zhifeng Chen; Kaibo Mei; Peng Yu; Lixia Xie
Journal:  PLoS One       Date:  2020-02-18       Impact factor: 3.240

10.  Effects of Preoperative HbA1c Levels on the Postoperative Outcomes of Coronary Artery Disease Surgical Treatment in Patients with Diabetes Mellitus and Nondiabetic Patients: A Systematic Review and Meta-Analysis.

Authors:  Jinjing Wang; Xufei Luo; Xinye Jin; Meng Lv; Xueqiong Li; Jingtao Dou; Jing Zeng; Ping An; Yaolong Chen; Kang Chen; Yiming Mu
Journal:  J Diabetes Res       Date:  2020-02-28       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.